Albemarle Corp (ALB)

Industry Specialty Chemicals


This stock can be held in an Investment ISA and an Investment Account
Sell

$143.15

Buy

$143.36

arrow-up$2.88 (+2.05%)

Prices updated at 19 Dec 2025, 15:05 EST
| Prices minimum 15 mins delay
|
Prices in USD

Albemarle Corp is a developer, manufacturer and marketer of engineered specialty chemicals. It provides services to end markets including petroleum refining, consumer electronics, construction, automotive, lubricants and pharmaceuticals.

Income statement

20232024
9,617m5,378m
1,186m63m
190m-642m
1.98-11.94
1,573m-1,179m
793m-1,010m
Sales, General and administrative910m618m
Interest expenses116m166m
Provision for income taxes430m87m
Operating expenses996m705m
Income before taxes247m-1,764m
Net income available to common shareholders1,573m-1,316m
13.41-11.2
Net interest income-116m-166m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)13.36-11.2
Free cash flow per share3.9454-12.0035
Book value/share84.340168.0972
Debt equity ratio0.3882930.416449

Balance sheet

20232024
Current assets5,217m3,842m
Current liabilities3,560m1,966m
Total capital12,953m13,080m
Total debt4,280m3,616m
Total equity9,412m9,962m
Total non current liabilities--
Loans3,541m3,118m
Total assets18,271m16,610m
Total liabilities--
Cash and cash equivalents890m1,192m
Common stock117m118m

Cash flow

20232024
Cash at beginning of period1,499m890m
Cash dividends paid-187m-311m
-824m-984m
Investments (gains) losses-2,781m-1,574m
890m1,192m
Net income--
1,325m702m
-2,149m-1,686m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.